Children With Surgically Corrected Acyanotic Congenital Heart Disease
Pediatrics
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this quasi-experimental pretest-posttest controlled study is to learn whether moderate-intensity treadmill exercise can improve gait kinematics, walking capacity, and motor performance in preschool children aged 48-72 months with surgically corrected acyanotic congenital heart disease. The main questions it aims to answer are: Does moderate-intensity treadmill training improve gait kinematics, including stride length, walking speed, and double-stance percentage? Does moderate-intensity treadmill training improve walking capacity and balance in children with surgically corrected acyanotic congenital heart disease? Researchers compared children with surgically corrected acyanotic congenital heart disease who received treadmill training with age-matched healthy children to see whether the exercise program could reduce gait, balance, and walking-capacity differences between the groups. Participants with congenital heart disease completed: Four treadmill walking sessions per week for 10 weeks. Moderate-intensity walking at approximately 70% of maximal heart rate. Pre- and post-intervention assessments of gait kinematics using three-dimensional motion analysis. Balance assessment using the Pediatric Balance Scale. Walking capacity assessment using the six-minute walk test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2026
CompletedFirst Posted
Study publicly available on registry
May 26, 2026
CompletedStudy Start
First participant enrolled
May 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
CompletedMay 26, 2026
April 1, 2026
3 months
May 9, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
gait parameters
Gait parameters, including stride length (cm), speed (meters/minute), and double stance percentage (%) of the dominant leg, were assessed using a 3D motion analysis system.
basiline pre-test assessment and after 10 weeks of interventions (post-intervention assessment)
Study Arms (2)
congenital heart disease
EXPERIMENTALThe children in this group received walking sessions weekly for 10 weeks.
healthy group
NO INTERVENTIONhealth control group
Interventions
4 sessions of walking on treadmill for 2.5 months
Eligibility Criteria
You may qualify if:
- For cyanotic postoperative congenital heart disease group:
- Children diagnosed with acyanotic postoperative congenital heart disease.
- Underwent surgical repair for CHD.
- Has a history of only one surgical intervention.
- Age between 48 and 72 months.
- Mentally normal, with an IQ between 85 and 115.
- For the healthy control group (HCG):
- For healthy children aged 48 to 72 months. Full school attendance. Full participation in social and recreational activities. Parents/guardians provided written informed consent.
You may not qualify if:
- Children were excluded if they had:
- Genetic disorders.
- Severe neurological disorders.
- Cyanotic congenital heart disease.
- Perinatal complications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amira Hussin Mohammed
Gamasa, 35712, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2026
First Posted
May 26, 2026
Study Start
May 31, 2026
Primary Completion
August 31, 2026
Study Completion
September 1, 2026
Last Updated
May 26, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
All the required data that support the conclusion will be available when requested.